Home › Funds › BVF INC/IL › ANNX
BVF INC/IL position in ANNX
ANNEXON INC COM · Health Care
BVF INC/IL reported holding 8,698,173 shares of ANNX (ANNEXON INC COM) in its Q2 2026 13F filing — a position valued at US$49.7M, representing 1.27% of its reported portfolio and ranking #19 among its reported holdings. BVF INC/IL has disclosed ANNX holdings in 11 of the last 11 reported quarters, going back to Q4 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How BVF INC/IL's ANNX position evolved
BVF INC/IL first disclosed a stake in ANNX in Q4 2023 at 7,000,000 shares (US$31.8M). The position peaked in Q1 2024 at 7,000,000 shares, worth US$50.2M. Across 11 filings, BVF INC/IL increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 8 time(s). The most recent filing (Q2 2026) shows 8,698,173 shares valued at US$49.7M. Notable position changes include a 30% increase in Q4 2025 (shares rose 10% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2023 | 7.00M | $31.78M | New |
| Q1 2024 | 7.00M | $50.19M | Hold |
| Q2 2024 | 7.00M | $34.30M | Hold |
| Q3 2024 | 7.00M | $41.44M | Hold |
| Q4 2024 | 7.00M | $35.91M | Hold |
| Q1 2025 | 7.00M | $13.51M | Hold |
| Q2 2025 | 7.00M | $16.80M | Hold |
| Q3 2025 | 7.00M | $21.35M | Hold |
| Q4 2025 | 9.13M | $45.82M | Add |
| Q1 2026 | 8.70M | $48.19M | Reduce |
| Q2 2026 | 8.70M | $49.67M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ANNX and 13F data
ANNX (ANNEXON INC COM) is a Health Care company. 45 other funds we track also report a position in ANNX — the largest reported positions include Redmile Group, LLC (US$67.8M), MAK CAPITAL ONE LLC (US$33.5M), Siren, L.L.C. (US$25.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ANNX
- Redmile Group, LLC 11.87M sh · $67.78M · Q2 2026
- MAK CAPITAL ONE LLC 5.86M sh · $33.47M · Q2 2026
- Siren, L.L.C. 4.46M sh · $25.46M · Q2 2026
- Bain Capital Life Sciences Investors, LLC 4.44M sh · $25.34M · Q2 2026
- Bellevue Group AG 4.10M sh · $23.41M · Q2 2026
- MPM BioImpact LLC 3.54M sh · $20.24M · Q2 2026
- GREAT POINT PARTNERS LLC 3.50M sh · $19.98M · Q2 2026
- Palo Alto Investors LP 2.95M sh · $16.83M · Q2 2026
- Opaleye Management Inc. 1.71M sh · $9.79M · Q2 2026
- Logos Global Management LP 1.50M sh · $8.56M · Q2 2026
- Tetragon Partners GP Ltd 1.24M sh · $7.09M · Q2 2026
- Ishara Investments LP 820.00K sh · $4.68M · Q2 2026
More on BVF INC/IL
FAQ
How long has BVF INC/IL held ANNX?
BVF INC/IL has disclosed ANNX holdings in 11 of the last 11 reported quarters, going back to Q4 2023.
What is BVF INC/IL's current position in ANNX?
As of Q2 2026, BVF INC/IL holds 8.70M shares of ANNX (ANNEXON INC COM), valued at $49.67M, representing 1.27% of its reported portfolio and ranking #19.
Has BVF INC/IL been buying or selling ANNX?
In the latest 13F filing (Q2 2026), BVF INC/IL held unchanged its position in ANNX. The position peaked in Q1 2024 at 7.00M shares.
Which other funds hold ANNX?
Other major institutional holders of ANNX include Redmile Group, LLC, MAK CAPITAL ONE LLC, Siren, L.L.C., among 45 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.